Therapeutics

Tools

Back to the Top
Search By Attributes

Search Results

Name Synonyms FDA Status Company Target Type Therapy Type Approved
For
ABBV-916 N3pG-Abeta mAb Alzheimer's Disease (Phase 2) Amyloid-Related Immunotherapy (passive)
SHR-1707 Alzheimer's Disease (Phase 2) Amyloid-Related Immunotherapy (passive)